Romanian Journal of Rheumatology (Jun 2017)

COULD ANTI-SYNTHETASE SYNDROME BE A GOOD PREDICTOR FACTOR FOR INTERSTITIAL LUNG DISEASE?

  • Sineta Cristina Firulescu,
  • Paulina Lucia Ciurea,
  • Cristina Dorina Parvanescu,
  • Beatrice Andreea Chisalau,
  • Andreea Lili Barbulescu,
  • Cristina Criveanu,
  • Adina Turcu-Stiolica,
  • Roxana Edmee Mustafa,
  • Florentin Ananu Vreju

DOI
https://doi.org/10.37897/RJR.2017.2.9
Journal volume & issue
Vol. 26, no. 2
pp. 96 – 100

Abstract

Read online

Anti-synthetase syndrome (SAS) is an autoimmune inflammatory myopathy, whose immune profile is dominated by anti-RNA synthetase antibodies (ARS), with a specific clinical phenotype. The major diagnostic criteria of SAS include the triad of myositis, arthritis and interstitial lung disease (ILD), on the background of positive anti-ARS antibodies. ILD in SAS, has a good evolution compared to the one in PM/DM, due to protective presence of anti Jo-1 antibodies.

Keywords